Consolidated Balance Sheets - USD ($)	Dec. 31, 2024	Dec. 31, 2023
CURRENT ASSETS:
Cash	$ 26,015
Accounts receivable	555,195
Note receivable	100,000
Interest receivable	5,326
TOTAL ASSETS	686,536
CURRENT LIABILITIES:
Accounts payable and accrued liabilities	26,381	281,716
Accrued compensation	56,666
Due to related parties	826
Notes payable	243,121
Derivative liability	510,154	293,621
Stock payable	36,130	36,130
Total Current Liabilities	1,280,041	850,078
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS’ DEFICIT:
Series A Preferred stock, 200,000 shares authorized, $0.001 par value; 100,000 and 100,000 issued and outstanding, respectively	100	100
Common stock, 2,499,900,000 shares authorized, $0.001 par value; 523,925,844 and 612,179,943 issued and outstanding, respectively	523,925	612,179
Additional paid-in capital	1,978,485	1,787,804
Accumulated deficit	(3,096,015)	(3,250,161)
Total Stockholders’ Deficit	(593,505)	(850,078)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	686,536
Related Party [Member]
CURRENT LIABILITIES:
Convertible notes payable	74,501	71,230
Accrued interest	11,075	7,555
Settlement liability		146,799
Nonrelated Party [Member]
CURRENT LIABILITIES:
Convertible notes payable	317,452
Accrued interest	3,735	3,426
Settlement liability		$ 9,601